The David Rubenstein Show: Peer-to-Peer Conversations

Noubar Afeyan (7x3)

Air date: Aug 18, 2021

Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the Covid-19 vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm, Flagship Pioneering, is looking for its next opportunity.